MedTrace Logo

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors

NCT01440504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2013-02-07

No results posted yet for this study

Summary

The aim of the study is to quantify the ex vivo induction of apoptosis by ABT-737 + association platinum in samples exposed and demonstrate the value of this combination compared to the agents used alone.

Conditions

Interventions

OTHER

culture ex vivo with exposure to different therapeutic agents alone or in combination.

When tumor resection, tumor specimens of ovarian cancer will be made towards a culture ex vivo with exposure to different therapeutic agents alone or in combination.

Sponsors & Collaborators

  • GRECAN

    collaborator UNKNOWN

  • Centre Francois Baclesse

    lead OTHER

Principal Investigators

  • JOLY Florence, Pr · Centre françois Baclesse

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01440504 on ClinicalTrials.gov